SARS-CoV-2 and pathological matrix remodeling mediators

Abstract

Background Recognizing only sharp elevation in a short period of time, the COVID-19 SARS-CoV-2 propagation is more and more marked in the whole world. Induced inflammation afterwards infection engenders a high infiltration of immune cells and cytokines that triggers matrix metalloproteinases (MMPs) activation. These endopeptidases are mediators of the lung extracellular matrix (ECM), a basic element for alveoli structure and gas exchange. Methods When immune cells, MMPs, secreted cytokines and several other mediators are gathered a pathological matrix remodeling occurs. This phenomenon tends to tissue destruction in the first place and a pulmonary hypertrophy and fibrosis in the second place. Findings After pathological matrix remodeling establishment, pathological diseases take place even after infection state. Since post COVID-19 pulmonary fibrosis is an emerging complication of the disease, there is an urge to better understand and characterize the implication of ECM remodeling during SARS-CoV-2 infection. Conclusion Targeting MMPs and their inhibitors could be a probable solution for occurred events since there are many cured patients that remain with severe sequels even after the end of infection.

Relationship Between Endothelial and Angiogenesis Biomarkers Envisage Mortality in a Prospective Cohort of COVID-19 Patients Requiring Respiratory Support

“…Early recognition of evolution is still not possible ( 1 – 3 ). Long-lasting hospitalisation due to prolonged mechanical ventilation is associated with altered oxygen diffusion in lung capillaries, which may be partly due to an increase in fibrotic areas ( 4 ). Angiopoietins are critical players in vessel maturation and mediate the migration, adhesion, and survival of endothelial cells.…”

A Real Pandora’s Box in Pandemic Times: A Narrative Review on the Acute Cardiac Injury Due to COVID-19

“…Even before the COVID-19 pandemic, the American Heart Association (AHA) suggested that viral infections could destabilize the atherosclerotic plaques, and various collagenolytic enzymes, such as matrix metalloproteinases (MMP), were becoming associated with increased plaque vulnerability [ 47 , 48 ]. Those MMPs can be activated by a plethora of cytokines (e.g., TNF-alpha, INF-γ, IL-1, and IL-6), thus diminishing the cohesion of the atherosclerotic plaque and consecutively increasing the risk of acute coronary syndromes [ 48 , 49 ]. Based on these observations, the COVID-19 pandemic again turned the spotlight on statins’ pleiotropic effects, primarily based on their anti-inflammatory response, doubled by the amelioration of the endothelial function.…”

COVID-19 and fibrosis: Mechanisms, clinical relevance, and future perspectives

“…Clinical cases of COVID-19 have also shown symptoms of remodelled matrices rich in collagens. 24 Despite no concrete evidence of long-term pulmonary fibrosis in survivors, this remodelling and developed fibrosis compromise organ function and, thus, requires research attention. The intricate relationship between inflammation, cytokine storm and fibrosis is detailed in Figure 1 .…”